IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Condi
RecruitingNCT07197138Phase: NAStarted 2025-09-11
Summary
This is a monocentric, randomized pilot study conducted at the Max Planck Institute of Psychiatry, Munich. The study investigates the effects of two different intermittent theta-burst stimulation (iTB
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Max-Planck-Institute of PsychiatryMunich, Bavaria, Germany
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07197138